Free shipping on all orders over $ 500

BYL-719

Cat. No. M2104

All AbMole products are for research use only, cannot be used for human consumption.

BYL-719 Structure
Synonym:

Alpelisib; BYL719

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 56 In stock
2mg USD 35 In stock
5mg USD 50 In stock
10mg USD 66 In stock
50mg USD 98 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Alpelisib (Byl-719) is an effective, selective PI3Kα inhibitor with oral activity. Alpelisib (Byl-719) was targeted to PIK3CA mutated carcinoma. The IC50 of Alpelisib (Byl-719) against P110 α, P110 γ, p110δ and P110 β were 5 nM, 250 nM, 290 nM and 1200 nM, respectively. It has antitumor activity.

Product Citations
Customer Product Validations & Biological Datas
Source Int J Cancer (2015). Figure 1. BYL719
Method Caspase 3/7 activity assay
Cell Lines HOS and MOS-J cells
Concentrations 25 μM
Incubation Time 24 and 48 hr
Results After 72 hr of treatment, BYL719 significantly inhibited the cell growth of all osteosarcoma cell lines tested in a dosedependent manner with an IC50 ranging from 6 to 15 μM and with the IC90 from 24 to 42 μM at 72 hr.
Chemical Information
Molecular Weight 441.47
Formula C19H22F3N5O2S
CAS Number 1217486-61-7
Solubility (25°C) DMSO 72 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Fabrice Andr, et al. Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer

[2] Dejan Juric, et al. Phosphatidylinositol 3-Kinase α-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study

[3] Ingrid A Mayer, et al. A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER+/HER2- Metastatic Breast Cancer

Related PI3K Products
AS605240

AS-605240 is a potent and selective inhibitor of PI 3-kinase γ (PI3Kγ) with an IC50 of 8 nM.

BEZ235

BEZ235 (NVP-BEZ235) is a potent dual PI3K and mTOR inhibitor of p110α, p110γ, p110δ and p110β with IC50 of 4 nM, 5 nM, 7 nM and 75 nM, respectively.

BKM120 (Buparlisib)

BKM120 (NVP-BKM120) is a potent and highly specific oral pan-class I PI3K inhibitor.

GDC-0941 (Pictilisib)

GDC-0941 is a selective and potent inhibitor of Class I PI3K, p110a IC50=0.003uM, U87MG IC50=0.95μM.

AS-252424

AS-252424 is a furan-2-ylmethylene thiazolidinedione as a selective ATP-competitive PI3Kγ inhibitor with IC50 with 33 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: BYL-719, Alpelisib; BYL719 supplier, PI3K, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.